EISAI CO
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 1941-12-06
- Employees
- 11K
- Market Cap
- $12B
- Website
- http://www.eisai.co.jp
A Study of E3810 for Japanese Subjects With Functional Dyspepsia (SAMURAI Study: Suppression of Acid Milieu With Rabeprazole Improving Functional Dyspepsia ) (Study E3810-J081-204)
- First Posted Date
- 2010-03-18
- Last Posted Date
- 2013-12-24
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 338
- Registration Number
- NCT01089543
A Pilot Cross-over Bioequivalence Study of E3810 for Healthy Japanese Male (Under Postprandial Condition)
- First Posted Date
- 2010-03-12
- Last Posted Date
- 2013-05-13
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT01085708
Study of E3810 for Healthy Japanese Male (Under Fasting Condition)
- First Posted Date
- 2010-03-12
- Last Posted Date
- 2013-05-13
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT01085695
Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT01063556
A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT01055834
A Study of MORAb-003 in Patients With Solid Tumor
- First Posted Date
- 2010-01-14
- Last Posted Date
- 2020-06-11
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT01049061
A Study of MORAb-009 in Patients With Solid Tumor
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2016-01-21
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 17
- Registration Number
- NCT01018784
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
- First Posted Date
- 2009-08-26
- Last Posted Date
- 2021-12-17
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 253
- Registration Number
- NCT00965757
Study of E7389 for Advanced or Metastatic Breast Cancer
- First Posted Date
- 2009-08-25
- Last Posted Date
- 2013-08-15
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 81
- Registration Number
- NCT00965523
Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC)
- First Posted Date
- 2009-07-24
- Last Posted Date
- 2019-02-01
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT00946153